Submit Deal

PIVOTAL BIOVENTURE PARTNERS LLC

HQ - San Francisco

Summary

Pivotal bioVenture Partners LLC operates as a venture capital firm. The Company makes early stage investments in biotechnology companies. Pivotal bioVenture Partners serves customers in the State of California.

Deals Overview

Total Deals11

Valued Deals10

Total Value£ 1.17 B

Avg. Deal Size£ 117 M

Market Context

Senior Management

Rob Hopfner
Managing Partner
Dianna Qian
Partner
Vincent Cheung
Founding Partner

Investment Criteria

Target Equity Check-

Fund CurrencyUSD

Total funds raisedn/a

Investment Strategies

Early Stage

Geographic Preferences

Canada

Mexico

United States

Industry Preferences

Pharmaceuticals and Biotechnology

Sort

05 Sep 2017|United States|Biotechnology

Target: ENTASIS THERAPEUTICS LIMITED

Bidder: CLARUS VENTURES LLC

3 Service Providers

3 Bidder

1 Dealmakers

3 Bidder

n/a

Value

19 May 2020|United States|Pharmaceuticals

Target: RALLYBIO

Bidder: PIVOTAL BIOVENTURE PARTNERS LLC

14 Service Providers

2 Target | 12 Bidder

28 Dealmakers

3 Target | 25 Bidder

£ 119 M

Value

11 Jan 2021|China|Pharmaceuticals

Target: VISEN PHARMACEUTICALS

Bidder: ORBIMED PE

12 Service Providers

1 Target | 11 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 111 M

Value

09 Mar 2021|China|Medical Services

Target: ARCTIC VISION

Bidder: LOYAL VALLEY CAPITAL

7 Service Providers

1 Target | 6 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 72 M

Value

04 May 2021|Switzerland|Pharmaceuticals

Target: OCULIS

Bidder: TEKLA CAPITAL MANAGEMENT LLC

13 Service Providers

2 Target | 11 Bidder

18 Dealmakers

5 Target | 13 Bidder

£ 40 M

Value

29 Nov 2021|United States|Biotechnology

Target: HOTSPOT THERAPEUTICS

Bidder: SOFINNOVA PARTNERS

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 74 M

Value

17 Oct 2022|Switzerland|Pharmaceuticals

Target: OCULIS

Bidder: TEKLA CAPITAL MANAGEMENT LLC

22 Service Providers

7 Target | 15 Bidder

25 Dealmakers

8 Target | 17 Bidder

£ 194 M

Value

07 Nov 2022|United States|Biotechnology

Target: ZENAS BIOPHARMA

Bidder: AGENT CAPITAL

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 103 M

Value

13 Feb 2024|United States|Biotechnology

Target: BIOAGE

Bidder: RTW INVESTMENTS

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 134 M

Value

07 May 2024|United States|Biotechnology

Target: ZENAS BIOPHARMA

Bidder: FEDERATED HERMES

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 160 M

Value

10 Jan 2025|Switzerland|Pharmaceuticals

Target: WINDWARD BIO

Bidder: OMEGA FUNDS

12 Service Providers

2 Target | 10 Bidder

23 Dealmakers

13 Target | 11 Bidder

£ 162 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy